| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.86B | 29.97B | 28.51B | 24.49B | 20.42B | 17.19B |
| Gross Profit | 19.16B | 19.32B | 17.90B | 15.42B | 12.57B | 11.01B |
| EBITDA | 10.44B | 10.66B | 10.70B | 9.94B | 9.17B | 7.55B |
| Net Income | 5.37B | 5.17B | 6.29B | 5.95B | 5.29B | 4.29B |
Balance Sheet | ||||||
| Total Assets | 58.54B | 58.54B | 57.18B | 54.98B | 50.11B | 42.69B |
| Cash, Cash Equivalents and Short-Term Investments | 18.73B | 18.73B | 21.66B | 25.43B | 22.73B | 18.89B |
| Total Debt | 76.00M | 76.00M | 83.00M | 58.00M | 117.00M | 128.00M |
| Total Liabilities | 4.43B | 4.43B | 4.85B | 5.15B | 4.70B | 3.49B |
| Stockholders Equity | 54.11B | 54.11B | 52.33B | 49.83B | 45.41B | 39.20B |
Cash Flow | ||||||
| Free Cash Flow | -1.16B | 599.00M | 129.00M | 4.31B | 4.62B | 2.52B |
| Operating Cash Flow | 2.01B | 7.02B | 7.81B | 8.03B | 6.56B | 6.38B |
| Investing Cash Flow | -1.29B | -7.15B | -6.64B | -4.02B | -2.17B | -3.44B |
| Financing Cash Flow | -801.50M | -3.90B | -3.70B | -3.25B | -2.44B | -2.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥189.24B | 21.64 | 6.47% | 3.17% | 1.96% | 22.78% | |
74 Outperform | €120.12B | 23.17 | 5.97% | 1.78% | 3.17% | 7.07% | |
73 Outperform | ¥144.72B | 31.16 | ― | 2.73% | 5.10% | -26.13% | |
69 Neutral | ¥65.66B | 14.38 | ― | 2.88% | 3.69% | 1.86% | |
68 Neutral | ¥798.63B | 53.45 | 10.09% | 0.82% | 13.53% | -7.39% | |
66 Neutral | ¥168.92B | 24.71 | 5.66% | 2.65% | 5.43% | -20.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |